N-formyl-1-aminopyrene: nitropyrene metabolite; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 124862 |
SCHEMBL ID | 4071127 |
MeSH ID | M0141461 |
Synonym |
---|
AKOS002384354 |
n-pyren-1-ylformamide |
103915-43-1 |
unii-0qg4iu067z |
nfap |
0qg4iu067z , |
formamide, n-1-pyrenyl- |
n-formyl-1-aminopyrene |
n-1-pyrenylformamide |
SCHEMBL4071127 |
1-pyrenylformamide # |
YRRFNWAQLGOASH-UHFFFAOYSA-N |
formamide, n-(4-pyrenyl)- |
formamide, n-(1-pyrenyl)- |
DTXSID30146142 |
n-formyl-1-amino pyrene |
Q27237106 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.56) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (20.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (80.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |